Login
Toggle navigation
Videos
Categories
Trending
Richard Hooper interviews David Grocott about HUBER+SUHNER's recent acquisition of Phoenix Dynamics Ltd.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Urs Ryffel is Chief Executive Officer, Huber + Suhner AG.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
The reasons why we invests in digital media|Kenneth Lerer,Managing Partner,Lerer Hippeau
00:10:00
Regulus Resources: Corporate Overview and Project Highlights
00:10:00
The Executive Director of The Naga Group AG discusses Cyprus as an ideal business location for ICT companies at the Invest Cyprus Roadshow (The Americas).
00:10:00
Josh Wolfe on OpenAI's Challenges and Microsoft's Strategic Moves | Josh Wolfe, Co-Founder, Lux Capital .
00:10:00
Tan Sri Dato' Seri Vincent Tan, Founder and Advisor of Berjaya Corporation Berhad, was named the 2023 Malaysia Real Estate Personality of the Year.|Tan Sri Dato' Seri Vincent Tanis the founder of Berjaya Corporation Berhad
00:10:00
Fusion Pharmaceuticals Secures $105 Million to Combat Drug-Resistant Cancers: A Breakthrough Led by CEO John Valliant
00:10:00
Socrates' Political Philosophy: Wisdom in Governance|Massimo Pigliucci, Professor, City University of New York
00:10:00
Kincora Copper: Advancing Significant Copper-Gold Exploration in Australia's Macquarie Arc
00:10:00
Enhancing Strategic Thought: Analytical and Creative Thinking Training by Kasikorn Asset Management | D4 Consultant - Professional Development Experts
00:10:00
Unlocking Financial Success: Scott Jensen on Real Estate Investment Planning | Scott Jensen - Financial Advisor of Renovate Financial Planning
00:10:00
BioInvent CEO Highlights Major Milestone and Future Goals | Dr. Martin Welschof, CEO , BioInvent International AB.
00:10:00
Biomarker testing could dramatically improve patient health outcomes|Francois Desjardins,Vice President,Bellus Health